The Palo Alto-based venture firm Frazier Life Sciences has closed a new venture capital fund for startup creation and investing in early-stage biotechnology companies, raising $1.3 billion.

Conditional legal conclusions: Buried in footnotes, the staff repeatedly warns that its legal conclusions only apply if all those factual assumptions are true - meaning any deviation in real-world ...

Global venture capital (VC) investment in generative artificial intelligence (GenAI) surged to $49.2 billion in the first half of 2025, outpacing the total for all of 2024 ($44.2 billion) and more ...